Stifel has upgraded IDEXX Laboratories Inc (IDXX) to Buy from Hold, reflecting a more optimistic outlook on the company's prospects. This change, effective October 30, 2025, comes as IDEXX's current stock price stands at $712.47.
Headquartered in Westbrook, Maine, IDEXX Laboratories engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock, poultry, dairy, and water testing markets. The firm employs approximately 11,000 full-time staff and offers a range of diagnostic solutions through its Companion Animal Group, Water quality products, and Livestock, Poultry and Dairy segments.
As of November 1, 2025, the analyst consensus for IDEXX is categorized as Buy, with 7 Strong Buy, 8 Buy, and 7 Hold ratings. Recent earnings performance has shown positive surprises, including a Q3 2025 EPS of $3.40, exceeding estimates by 6.5%. Upcoming earnings are anticipated on August 2, 2026, with an estimated EPS of $3.98 and revenue of $1.2 billion.
Analyst ratings and price targets provide insights based on research and financial models. While they can inform investment decisions, it is important to consider multiple factors, including company fundamentals, competitive positioning, and broader industry trends. Analyst opinions may vary and can evolve as new information becomes available.
This update provides insight into the changing perceptions of market analysts regarding IDEXX Laboratories and highlights the importance of ongoing evaluation in investment strategies.